RecruitingRecruiting
Morphine or Ketamine for Analgesia
NCT06835504 · Columbia University
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Efficacy of Intravenous Sub-Dissociative Ketamine Versus Intravenous Morphine in Children With Acute Pain
About this study
Aim 1: To determine if IV sub-dissociative ketamine is non-inferior to IV morphine for decreasing pain intensity in children presenting to an ED with acute pain. The investigators hypothesize that IV sub-dissociative ketamine is non-inferior to IV morphine for decreasing pain intensity in children with acute abdominal pain or an extremity fracture.
Aim 2: To compare the rate of acute (\<2 hours) adverse events, including cardiopulmonary adverse events requiring an intervention, associated with IV sub-dissociative ketamine and IV morphine. The investigators hypothesize that there is a smaller proportion of cardiopulmonary adverse events requiring an intervention associated with IV sub-dissociative ketamine compared to IV morphine.
Aim 3: To determine the relationship between ketamine and long-term sequelae of acute pain. The investigators hypothesize that children who receive ketamine will have better levels of pain-related function during the first week following ED presentation and will have greater odds of experiencing more favorable post-traumatic stress, anxiety and depression outcomes 1-6 months after ED presentation compared to children who received IV morphine.
Eligibility criteria
Inclusion Criteria:
1. Age 6 to \< 18 years old
2. Chief complaint includes abdominal pain OR isolated long-bone extremity fracture (suspected or proven)
3. Self-reported pain score of ≥ 6/10
4. Requires IV morphine for analgesia as determined by the treating physician
Exclusion Criteria:
1. Weighs more than 81.9 kg
2. Known allergy/contraindication to morphine or ketamine
3. Antecedent receipt of ketamine related to presenting complaint
4. Inability to use self-report measures of pain or questionnaires
5. Chronic disease associated with pain
6. Chronic pain conditions requiring use of opioids as an outpatient
7. Abnormal vital signs at baseline, defined as oxygen saturation \<92% and/or low respiratory rate and/or low heart rate and/or low blood pressure per age
8. Altered mental state (e.g., GCS \< 14 or clinical intoxication)
9. Known history of schizophrenia, liver or kidney problems, or osteogenesis imperfecta
10. Concern for open fracture, neurovascular compromise, or compartment syndrome
11. Injuries in addition to the extremity injury (e.g., head, neck, abdomen)
12. Known or reported pregnancy
13. Patients who are breastfeeding
14. Patient or parent/guardian does not speak English or Spanish
15. Patient previously enrolled in this study
16. Known significant or uncontrolled cardiovascular disease
17. Known increased intracranial pressure and/or elevated intraocular pressure
18. Currently taking or having used a monoamine oxidase inhibitor within 14 days
19. Wards of state, foster children, or children in custody
Study design
Enrollment target: 1010 participants
Allocation: randomized
Masking: quadruple
Age groups: child
Timeline
Starts: 2026-10-17
Estimated completion: 2030-04-23
Last updated: 2026-10-20
Interventions
Drug: Ketamine hydrochlorideDrug: Morphine sulphate
Primary outcomes
- • Pain intensity (Up to 240 minutes after completion of study drug administration or until a terminal event occurs)
- • Cardiopulmonary adverse events requiring an intervention (Up to 120 minutes after completion of study drug administration or until a terminal event occurs)
- • Pain-related function (Days 1, 2,3, and 7 after discharge.)
Sponsor
Columbia University · other
With: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Neurological Disorders and Stroke (NINDS)
Contacts & investigators
ContactDaniel S Tsze, MD, MPH · contact · dst2141@cumc.columbia.edu · 917-375-2647
ContactAmy L Drendel, DO, MS · contact · adrendel@mcw.edu
InvestigatorDaniel S Tsze, MD, MPH · principal_investigator, Columbia University
InvestigatorAmy L Drendel, DO, MS · principal_investigator, Medical College of Wisconsin
All locations (8)
Children's Hospital Los AngelesNot Yet Recruiting
Los Angeles, California, United States
UC Davis Children's HospitalRecruiting
Sacramento, California, United States
Nemours Children's HospitalRecruiting
Wilmington, Delaware, United States
Arthur M. Blank HospitalNot Yet Recruiting
Atlanta, Georgia, United States
NewYork Presbyterian Morgan Stanley Children's HospitalNot Yet Recruiting
New York, New York, United States
UPMC Children's Hospital of PittsburghNot Yet Recruiting
Pittsburgh, Pennsylvania, United States
Seattle Children's HospitalRecruiting
Seattle, Washington, United States
Children's WisconsinRecruiting
Milwaukee, Wisconsin, United States